Jefferies Financial Group’s ResMed RMD Stock Holding History

Jefferies Financial Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$16.9M	Sell	76,568 -27,265	-26%	-$5.95M	0.13%	138
2026 Q2	$20.2M	Buy	103,833 +99,544	+2,321%	+$20.6M	0.13%	150
2026 Q1	$963K	Sell	4,289 -10,030	-70%	-$2.5M	0.01%	940
2025 Q4	$3.45M	Sell	14,319 -7,516	-34%	-$1.92M	0.02%	593
2025 Q3	$5.98M	Buy	21,835 +17,317	+383%	+$4.73M	0.03%	320
2025 Q2	$1.17M	Sell	4,518 -10,782	-70%	-$2.57M	0.01%	682
2025 Q1	$3.42M	Buy	15,300 +7,994	+109%	+$1.87M	0.03%	408
2024 Q4	$1.67M	Sell	7,306 -6,271	-46%	-$1.51M	0.01%	731
2024 Q3	$3.31M	Sell	13,577 -147,336	-92%	-$32.9M	0.02%	425
2024 Q2	$31.1M	Buy	160,913 +146,613	+1,025%	+$29.7M	0.33%	51
2024 Q1	$2.83M	Buy	+14,300	New	+$2.62M	0.03%	471
2023 Q4	–	Sell	-10,211	Closed	-$1.51M	–	1946
2023 Q3	$1.51M	Buy	+10,211	New	+$1.85M	0.01%	699
2023 Q1	–	Sell	-10,000	Closed	-$2.08M	–	1941
2022 Q4	$2.08M	Buy	+10,000	New	+$2.2M	0.01%	642

Other funds holding RMD

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Jefferies Financial Group's RMD Position: Q3 2026 in Review

Jefferies Financial Group reduced its ResMed (RMD) stake by 26% in Q3 2026, selling an estimated $5.95M and leaving 76,568 shares worth $16.9M. The position accounts for 0.13% of the portfolio, ranked #138.

Jefferies Financial Group first reported a position in RMD in Q4 2022 and has held it in 13 quarters since. The position peaked at $31.1M in Q2 2024. 535 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

Jefferies Financial Group held 76,568 shares of ResMed worth $16.9M as of Q3 2026.
Jefferies Financial Group sold 27,265 ResMed shares in Q3 2026, an estimated $5.95M.
ResMed made up 0.13% of Jefferies Financial Group's portfolio in Q3 2026, its #138 holding.
Jefferies Financial Group first reported a position in ResMed in Q4 2022 and has held it in 13 quarters since.
Jefferies Financial Group's ResMed position peaked at $31.1M in Q2 2024.
535 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.